English | Español
Patient Daily | Jul 20, 2026

AI-guided technique may improve targeted therapy for brain tumors
Patient Daily | Jul 20, 2026

Researchers review risks of prenatal use of medications affecting fetal brain development
Patient Daily | Jul 20, 2026

Eli Lilly to acquire AtaiBeckley for up to $3.8 billion in psychedelics sector move
Patient Daily | Jul 20, 2026

Dissolving microneedles may enhance photodynamic therapy for skin cancer, study finds
Patient Daily | Jul 20, 2026

Study finds global road injuries remain a leading cause of death and disability
Patient Daily | Jul 20, 2026

Researchers identify why rare neurological disease targets specific brain regions
Patient Daily | Jul 20, 2026

Review examines role of gut microbiome in stress-related mental disorders
Patient Daily | Jul 20, 2026

FARE introduces food allergy documentary short for national public television distribution

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'